Wide Ranks

ICLR

ICON plc

212.84

Top Statistics
Market Cap 17 B Forward PE 14.12 Revenue Growth -1.20 %
Current Ratio 1.34 Trailing PE 23.70 Earnings Growth 19.80 %
Profit Margins 9.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 12.16 Enterprise / Revenue 2.47 Price To Sales Trailing12 Months 2.12
Profitability
Profit Margins 9.00 % Operating Margins 14.45 %
Balance Sheet
Total Cash 695 M Total Cash Per Share 8.42 Total Debt 3 B
Total Debt To Equity 37.00 Current Ratio 1.34 Book Value Per Share 118.39
All Measures
Short Ratio 72.00 % Message Board Id finmb_397809 Fax 353 1 247 6260
Shares Short Prior Month 1 M Return On Equity 0.0799 City Dublin
Uuid b2bb319f-0763-3a31-bb0d-c06ea5b90dbf Previous Close 212.15 First Trade Date Epoch Utc 895 M
Book Value 118.39 Beta 1.25 Total Debt 3 B
Volume 452150 Price To Book 1.80 Last Split Date 1 B
Fifty Two Week Low 183.38 Total Cash Per Share 8.42 Total Revenue 8 B
Shares Short Previous Month Date 1 B Target Median Price 277.50 Max Age 86400
Recommendation Mean 1.50 Sand P52 Week Change 0.3133 Operating Margins 14.45 %
Target Mean Price 276.06 Net Income To Common 747 M Short Percent Of Float 0.0156
Implied Shares Outstanding 82 M Trailing Peg Ratio 99.56 % Last Fiscal Year End 1 B
Average Daily Volume10 Day 1 M Average Volume10days 1 M Total Cash 695 M
Next Fiscal Year End 1 B Revenue Per Share 100.52 Held Percent Insiders 0.0065
Ebitda Margins 20.29 % Trailing PE 23.70 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 212.15 Target Low Price 232.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 252.95 Open 213.82
Free Cashflow 1 B Dividend Yield 0.00 % Return On Assets 0.0417
Time Zone Short Name EST Trailing Eps 8.98 Day Low 209.72
Address1 South County Business Park Shares Outstanding 82 M Price Hint 2
Target High Price 300.00 Website https://www.iconplc.com 52 Week Change -0.2027
Average Volume 1 M Earnings Quarterly Growth 20.40 % Forward Eps 15.07
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 129.10 %
Last Split Factor 2:1 Regular Market Day High 215.08 Is_sp_500 False
Profit Margins 9.00 % Debt To Equity 37.00 Fifty Two Week High 347.72
Day High 215.08 Shares Short 1 M Regular Market Open 213.82
Industry Key diagnostics-research Earnings Growth 19.80 % Enterprise To Revenue 2.47
Revenue Growth -1.20 % Shares Percent Shares Out 0.0155 Operating Cashflow 1 B
Currency USD Time Zone Full Name America/New_York Market Cap 17 B
Is_nasdaq_100 False Zip D18 X5R3 Quote Type EQUITY
Industry Diagnostics & Research Long Name ICON Public Limited Company Regular Market Day Low 209.72
Held Percent Institutions 1.01 Current Price 212.84 Address2 Leopardstown
Enterprise To Ebitda 12.16 Financial Currency USD Current Ratio 1.34
Gross Margins 29.64 % Industry Disp Diagnostics & Research Number Of Analyst Opinions 16
Country Ireland Float Shares 81 M Two Hundred Day Average 301.29
Enterprise Value 20 B Price To Sales Trailing12 Months 2.12 Forward PE 14.12
Regular Market Volume 452150 Ebitda 1 B Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.

It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization.

In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers.

Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions.

The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations.

ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.